FindTrial
Sign In

A new intracanal medicament in root canal patients

Efficacy of a novel intracanal medicament on total antioxidant status in patients with apical periodontitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019420
Enrollment
42
Registered
2019-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Hekla Lava: Hekla Lava is used in tablet form which is triturated with the liquid dilution. Control Intervention1: calcium hydroxide: calcium hydroxide powder will be mixed with propyle

Sponsors

Avekash Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy individuals with symptomatic apical periodontitis. Non vital teeth

Exclusion criteria

Exclusion criteria: Immunocompromised patients vital teeth pregnant patients patients on medications

Design outcomes

Primary

MeasureTime frame
Total antioxidant capacityTimepoint: samples to be collected on first appointment and one week after placement of medicament—

Secondary

MeasureTime frame
to check pain before and after treatmentTimepoint: before and after using the medicament—

Countries

India

Contacts

Public ContactAishwarya Das

Saveetha Dental College

nasimiffat@gmail.com9940063567

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026